Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Monica Cojoc,1 Claudia Peitzsch,1 Franziska Trautmann,1 Leo Polishchuk,2 Gennady D Telegeev,2 Anna Dubrovska11OncoRay National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Dresden, Germany; 2Institute of Molecular Biology and Genetic...
Main Authors: | Cojoc M, Peitzsch C, Trautmann F, Polishchuk L, Telegeev GD, Dubrovska A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-09-01
|
Series: | OncoTargets and Therapy |
Online Access: | http://www.dovepress.com/emerging-targets-in-cancer-management-role-of-the-cxcl12cxcr4-axis-a14522 |
Similar Items
-
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
by: Yi Shi, et al.
Published: (2020-12-01) -
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
by: Hara Takahiko, et al.
Published: (2014-05-01) -
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
by: Tripti Khare, et al.
Published: (2021-07-01) -
The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases
by: Eva M. García-Cuesta, et al.
Published: (2019-08-01) -
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System
by: Federica Barbieri, et al.
Published: (2014-01-01)